Greetings from
Freyr Bangladesh
With its significant socio-economic developments in recent years, and being well-known for technologically advanced pharmaceutical sector, Bangladesh offers deserved growth opportunities for foreign Medical Device / Medicinal product manufacturers who are willing to enter the region. Under the Ministry of Health & Welfare, Drug Control Committee (DCC), and the Director General of Drug Administration of Bangladesh (DGDA) supervises the drug regulations in the country. With the complex procedures need to be followed for the registrations, lack of comprehensive Regulatory knowledge would pose a great challenge for manufacturers to get market approvals.
Freyr, as a specialist Regulatory partner, assists foreign manufacturers to be abreast with the Bangladesh Regulatory regime and helps them navigate through complex procedures for successful market authorizations. Freyr’s end-to-end Regulatory services for Bangladesh span across:
- Medical Devices
- Drugs
Freyr Offerings
- Strategic Regulatory Consulting
- Regulatory Affairs & Regulatory intelligence
- Registration pathways and license management services
Freyr Advantages
- Strategic and well-versed local regulatory knowledgebase – with DCC, DGDA
- Expert Regulatory team with proven global RA expertise
- Proactive and Collaborative approach
- Quick turnarounds and faster time-to-market
- Keeping abreast with region-specific legislation and Regulatory guidelines